Ehsan, Nava http://orcid.org/0000-0001-7453-2518
Kotis, Bence M.
Castel, Stephane E.
Song, Eric J.
Mancuso, Nicholas http://orcid.org/0000-0002-9352-5927
Mohammadi, Pejman http://orcid.org/0000-0003-4457-8552
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM140287, R01GM140287, R01GM140287)
Takeda Pharmaceuticals U.S.A.
Skaggs Scholars Program
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (1K99HG009916-01)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
Article History
Received: 31 January 2022
Accepted: 30 December 2023
First Online: 15 January 2024
Competing interests
: S.E.C. is a co-founder, Chief Technology Officer, and stock owner at Variant Bio. The remaining authors declare no competing interests.